Lumonus
Lumonus is an AI-powered oncology platform serving radiation oncology care teams at cancer centers and health systems, automating consultation, documentation, and treatment planning workflows across 95 clinics in four countries.
- Company typePrivate
- Founded2019
- HeadquartersNorth Sydney, Australia
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Lumonus does
Lumonus is an Australian-headquartered healthcare technology company that builds an AI-powered oncology intelligence platform for radiation oncology workflows. Founded in 2019 and operating as Lumonus Pty Ltd from Sydney with a US regional presence in New York, the company serves cancer centers, hospitals, and radiation oncology networks through two flagship products: Lumonus AI Physician (consult, document, and improve modules for radiation oncologists) and Lumonus AI Dosimetry (manage, plan, review, and improve modules for treatment planning). The platform integrates with existing EMR, OIS, and TPS systems and is built on a three-layer Oncology Intelligence Layer architecture combining Knowledge Management, an Automation Engine, and a Learning System that generates real-world data from care delivery.
The company's technical foundation spans large language models for clinical document processing (AI Consult), a constraint-based mathematical optimization engine licensed from Memorial Sloan Kettering (ECHO), and an evidence-based directives library licensed from Northwell Health's Smarter Radiation Oncology (approximately 170 protocols refined over 15-16 years). Lumonus generates revenue through multi-year enterprise SaaS subscriptions with quote-based pricing for healthcare organizations, supported by a direct enterprise field sales motion and dedicated clinical success teams. To date the platform has supported more than 280,000 cancer treatments, automated over 75,000 treatment plans, and is deployed across 95 clinics in the United States, Australia, New Zealand, and the United Kingdom, with named customers including UMass Chan Medical School-Baystate, Northwell Health, US Oncology, St Vincent's-Genesicare, Maimonides Health, and Tacoma Radiation Oncology Centers.
Lumonus has raised A$28 million in a Series B financing led by Aviron Investment Management with Oncology Ventures, Brandon Capital, and Investible, with proceeds directed toward US market expansion, clinical informatics investment, and scaling of the flagship products. The leadership team includes CEO Keith Hansen, Chairman Merrick Howes, CPO Dr. Tim Fox (PhD, DABR; 30 years in radiation oncology), and a broader team of radiation oncologists, physicists, dosimetrists, and engineers with more than 100 years of combined clinical, operational, and technical experience.
Lumonus firmographics
Firmographics- Name
- Lumonus
- Legal name
- Lumonus Pty Ltd
- Website
- https://lumonus.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Lumonus is an AI-powered oncology platform serving radiation oncology care teams at cancer centers and health systems, automating consultation, documentation, and treatment planning workflows across 95 clinics in four countries.
- Ownership category
- akta.pro rank
Lumonus industry classification
Industry- Product category
- Radiation Oncology AI Software
- NAICS
- Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370), Services-Health Services (8000)
- akta.pro primary industry
- Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE)
Keywords
Where Lumonus is headquartered
LocationHeadquarters
- HQ city
- North Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Lumonus business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: AI-powered oncology workflow platform delivered as subscription service to healthcare organizations including cancer centers, hospitals, and radiation oncology networks globally.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise healthcare subscription model |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Lumonus product offering
Product offeringCore offering
Lumonus provides an AI-powered oncology workflow platform (Lumonus AI) purpose-built for radiation oncology care teams. Its two flagship products are Lumonus AI Physician, which acts as a context-aware clinical assistant for consulting, prescribing, and documentation with embedded analytics, and Lumonus AI Dosimetry, a treatment planning platform that automates over 80% of treatment plans and integrates with treatment planning systems. The platform sits on top of existing EMR, OIS, and TPS systems as an Oncology Intelligence Layer and is sold to hospitals, cancer centers, and radiation oncology networks via multi-year enterprise subscriptions.
Product overview
Lumonus offers a unified AI-powered oncology intelligence platform called Lumonus AI, comprising two core products: Lumonus AI Physician for radiation oncologists and Lumonus AI Dosimetry for dosimetrists, both powered by an Oncology Intelligence Layer that integrates with existing EMR, OIS, and TPS systems. The platform automates critical oncology workflows including consulting, documentation, treatment planning, and quality analytics, supporting over 280,000 cancer treatments globally.
Differentiator
Problem solved
Functional benefit
Brands
- Lumonus AI: AI-powered digital oncology platform that transforms cancer care through AI-native clinical infrastructure, automating and orchestrating critical oncology workflows.
- Lumonus AI Physician
- Lumonus AI Dosimetry
- AI Consult
Products and services
- Lumonus AI Physician Context-aware AI clinical assistant for radiation oncologists that supports consulting, prescribing, and automated documentation, with embedded clinical and operational analytics dashboards. Features include patient summaries with links to source data, chronological timeline views, chat with the patient chart, automated diagnosis from documents, and protocol recommendations. Built for physicians at cancer centers and hospitals and integrates with existing EMR, OIS, and TPS systems.
- Lumonus AI Dosimetry Treatment planning platform that automates over 80% of radiation therapy treatment plans and provides a centralized planning workspace, web-enabled approval experience, and embedded analytics. Integrates with treatment planning systems (TPS) and is designed for dosimetrists, physicists, and radiation oncology departments at hospitals and cancer centers.
Companies that use Lumonus
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles2 records
Lumonus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature5 records
Lumonus partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core/flagship.
- Memorial Sloan Kettering Cancer Center (MSK)core/flagshipStrategic collaboration to license and co-develop MSK's ECHO mathematical optimization engine into the Lumonus AI platform for radiation oncology treatment planning. The ECHO engine uses constraint-based mathematical methods developed over nearly a decade of clinical use. Partnership includes joint research to advance automated radiation therapy treatment planning, combining clinically validated optimization methods with modern workflow tools to improve quality, consistency, and efficiency. Goal is to move automation from promising research results to scaled, routine clinical deployment.
- Smarter Radiation Oncology (SRO) / Northwell Healthcore/flagshipMulti-year licensing agreement with Smarter Radiation Oncology, a company incubated by Northwell Health. SRO's evidence-based treatment protocols (developed over 16 years across 21 hospitals) will be embedded into the Lumonus AI Physician platform. This enables cancer centers to access validated, real-world prescribing standards directly at point of care, supporting faster, safer, and more consistent treatment decisions. SRO's directives guide nearly 90% of treatments across Northwell's cancer centers.
- Northwell Health - Smarter Radiation Oncology Divisioncore/flagshipMulti-year agreement to embed Smarter Radiation Oncology's library of approximately 170 evidence-based radiotherapy directives into Lumonus AI platform. Directives developed over 15-16 years based on clinical consensus have been used to treat approximately 80,000-85,000 patients, aimed at standardizing radiation oncology care in community settings and expanding access to validated prescribing standards.
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Lumonus competitors and assessment
Company assessmentBroad incumbents
- Varian (Siemens Healthineers): Dominant radiation oncology treatment planning and oncology information systems vendor, now part of Siemens Healthineers. Overlaps with Lumonus in TPS, OIS, and increasingly AI-driven planning workflows.
- Elekta: Global radiation therapy and radiosurgery hardware/software vendor. Competes in oncology information systems and treatment planning where Lumonus AI Physician and AI Dosimetry operate.
- Accuray: Radiation therapy device and software vendor (CyberKnife, TomoTherapy). Operates in the same radiation oncology ecosystem where Lumonus's AI planning and consultation tools are deployed.
- Flatiron Health (Roche): Oncology-specific electronic health record and real-world evidence platform. Comparable to Lumonus in oncology-specific data infrastructure, learning systems, and clinical workflow software.
- Tempus AI: AI-driven precision medicine and oncology data platform. Overlaps with Lumonus in oncology-specific AI, real-world evidence, and clinical decision support workflows.
Direct peers
- RaySearch Laboratories: Specialist vendor of treatment planning software (RayStation) and oncology information systems. Closest direct comparable in radiation oncology planning automation and machine learning optimization.
- MIM Software: Medical imaging and AI software for radiation oncology and radiology, including auto-contouring and treatment planning analytics. Direct overlap with Lumonus's AI-driven workflow automation.
Emerging players
- Paige.AI: AI-driven clinical decision support in oncology (digital pathology). Comparable as an AI-native oncology workflow company targeting enterprise health systems, though focused on pathology rather than radiation oncology.
- Arterys: Cloud-native AI platform for medical imaging and clinical workflows. Comparable to Lumonus in cloud-native AI architecture and healthcare workflow integration approach.
- DeepHealth (RadNet): AI-powered radiology and oncology workflow software now part of RadNet. Comparable in cloud-native, AI-first clinical workflow orchestration targeting enterprise imaging/oncology providers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Lumonus social profiles
Digital presenceLumonus compliance and trust
Trust signalCompliance1 record
Lumonus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lumonus leadership team
Management profileNumber of profiles
Profiles8 records
Lumonus funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lumonus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lumonus
What does Lumonus do?
Lumonus provides an AI-powered oncology workflow platform (Lumonus AI) purpose-built for radiation oncology care teams. Its two flagship products are Lumonus AI Physician, which acts as a context-aware clinical assistant for consulting, prescribing, and documentation with embedded analytics, and Lumonus AI Dosimetry, a treatment planning platform that automates over 80% of treatment plans and integrates with treatment planning systems. The platform sits on top of existing EMR, OIS, and TPS systems as an Oncology Intelligence Layer and is sold to hospitals, cancer centers, and radiation oncology networks via multi-year enterprise subscriptions.
Is Lumonus a public or private company?
Lumonus is a private company. It is classified as venture growth investor backed and is currently operating.
When was Lumonus founded?
Lumonus was founded in 2019. It employs 51 to 100 people.
Where is Lumonus based?
Lumonus is headquartered in North Sydney, Australia, in the Oceania region.
How does Lumonus make money?
One revenue line is on record: saaS Platform Subscription.
Who are Lumonus's main competitors?
Broad incumbents on record are Varian (Siemens Healthineers), Elekta, Accuray, Flatiron Health (Roche) and Tempus AI. Direct peers are RaySearch Laboratories and MIM Software. Emerging players are Paige.AI, Arterys and DeepHealth (RadNet).
Does Lumonus have an API?
No public API is recorded for Lumonus.
What industry is Lumonus in?
Lumonus's product category is Radiation Oncology AI Software. Its primary akta.pro industry code is HLAAANAE, Clinical Decision Support & Workflow Integration (EHR/oncology systems). Its NAICS code is 54151 and its SIC code is 7370.